Literature DB >> 8335415

Myocardial infarction in a young adult due to Kawasaki disease. A case report and review of the late cardiological sequelae of Kawasaki disease.

N Shaukat1, S Ashraf, A Mebewu, A Freemont, D Keenan.   

Abstract

Although Kawasaki disease is generally self-limiting, 15-25% of children with Kawasaki disease may develop significant cardiovascular sequelae, presentation may occur acutely or late (death has been reported up to 14 years after the acute illness). The most common late complication is the persistence of coronary artery aneurysms, these may produce myocardial ischaemia and even myocardial infarction, valvular dysfunction has also been reported. However the occurrence of late abnormalities of myocardial function is controversial. We describe a 24-year-old man who presented with myocardial infarction as a result of coronary artery aneurysms caused by Kawasaki disease, he gave no recent or childhood history of prodromal illness compatible with Kawasaki disease. The diagnosis was confirmed at post mortem.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8335415     DOI: 10.1016/0167-5273(93)90044-h

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  4 in total

Review 1.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

2.  Anaesthetic management for caesarean section in a patient with Kawasaki disease.

Authors:  S Alam; S Sakura; Y Kosaka
Journal:  Can J Anaesth       Date:  1995-11       Impact factor: 5.063

3.  ST-segment elevation myocardial infarction in Kawasaki disease: A case report and review of literature.

Authors:  Joonpyo Lee; Jeongduk Seo; Yong Hoon Shin; Albert Youngwoo Jang; Soon Yong Suh
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

Review 4.  Cardiac surgical procedures for the coronary sequelae of Kawasaki disease.

Authors:  Shi-Min Yuan
Journal:  Libyan J Med       Date:  2012-12-03       Impact factor: 1.657

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.